1. Home
  2. RVNC vs CRESY Comparison

RVNC vs CRESY Comparison

Compare RVNC & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • CRESY
  • Stock Information
  • Founded
  • RVNC 1999
  • CRESY 1936
  • Country
  • RVNC United States
  • CRESY Argentina
  • Employees
  • RVNC N/A
  • CRESY N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • CRESY Real Estate
  • Sector
  • RVNC Health Care
  • CRESY Finance
  • Exchange
  • RVNC Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • RVNC 599.6M
  • CRESY 568.6M
  • IPO Year
  • RVNC 2014
  • CRESY 1997
  • Fundamental
  • Price
  • RVNC $3.84
  • CRESY $11.24
  • Analyst Decision
  • RVNC Buy
  • CRESY
  • Analyst Count
  • RVNC 10
  • CRESY 0
  • Target Price
  • RVNC $10.23
  • CRESY N/A
  • AVG Volume (30 Days)
  • RVNC 2.9M
  • CRESY 247.0K
  • Earning Date
  • RVNC 11-07-2024
  • CRESY 11-08-2024
  • Dividend Yield
  • RVNC N/A
  • CRESY 6.63%
  • EPS Growth
  • RVNC N/A
  • CRESY N/A
  • EPS
  • RVNC N/A
  • CRESY N/A
  • Revenue
  • RVNC $256,945,000.00
  • CRESY $751,941,316.00
  • Revenue This Year
  • RVNC $20.36
  • CRESY N/A
  • Revenue Next Year
  • RVNC $31.66
  • CRESY N/A
  • P/E Ratio
  • RVNC N/A
  • CRESY N/A
  • Revenue Growth
  • RVNC 25.82
  • CRESY N/A
  • 52 Week Low
  • RVNC $2.30
  • CRESY $6.56
  • 52 Week High
  • RVNC $9.75
  • CRESY $11.65
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 34.28
  • CRESY 70.70
  • Support Level
  • RVNC $3.64
  • CRESY $9.76
  • Resistance Level
  • RVNC $4.37
  • CRESY $11.55
  • Average True Range (ATR)
  • RVNC 0.33
  • CRESY 0.53
  • MACD
  • RVNC -0.11
  • CRESY 0.13
  • Stochastic Oscillator
  • RVNC 18.39
  • CRESY 84.35

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: